Account
Inquiry
Tirzepatide 15mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide mimics the action of endogenous incretins to enhance insulin secretion and suppress glucagon levels.
The tirzepatide 15mg formulation contains a 39-amino acid peptide backbone with two non-natural residues (Aib at positions 2 and 13) and a C20 fatty diacid side chain at Lys20, contributing to its extended half-life of approximately 117 hours.
As a research compound, tirzepatide 15mg has shown potential in metabolic studies due to its ability to delay gastric emptying and reduce appetite. These properties make it valuable for investigating mechanisms of glycemic control and weight management.
The tirzepatide 15mg peptide is supplied as a lyophilized powder in sterile vials. Each batch undergoes rigorous quality control testing including HPLC, MS, and AAA to ensure purity and consistency.
Our manufacturing facility produces tirzepatide 15mg under strict GMP conditions, with scalable production capabilities from milligram-scale research batches to multi-kilogram quantities. The peptide is available in various packaging configurations to meet different research requirements.
Note: This product is for research use only. Not for human consumption.
